SCHEMBL528018

SCHEMBL528018

COc1ccccc1Cc1c(C2CCNCC2)ccnc1C(N)=O

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 7/20 0.48
▸ SLC6A4 P31645 7/20 0.48
▸ HTR1A P08908 6/20 0.48
▸ SLC6A3 Q01959 4/20 0.48
▸ HTR2C P28335 3/20 0.46
▸ NR3C1 P04150 1/20 0.41
▸ MAP4K1 Q92918 1/20 0.41
▸ CCR2 P41597 1/20 0.40
▸ GNAI3 P08754 1/20 0.39
▸ CCNT1 O60563 1/20 0.39
▸ CDK9 P50750 1/20 0.39
▸ HTR6 P50406 1/20 0.38
▸ CDK1 P06493 1/20 0.38
▸ CDK4 P11802 1/20 0.38
▸ CCND1 P24385 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ PNP P00491 1/20 0.38
▸ NR3C2 P08235 1/20 0.38
▸ PTPN11 Q06124 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30006783 0.72 TDP1 (0.49) NR3C2
SCHEMBL21722444 0.72 TDP1 (0.49) NR3C2
SCHEMBL528021 0.70 HTR1A (0.42) SLC6A2SLC6A4HTR1ASLC6A3HTR2C
SCHEMBL30671511 0.68 HTR6 (0.36) SLC6A2SLC6A4HTR1ASLC6A3HTR6
SCHEMBL28727044 0.68 HTR2C (0.69) SLC6A2SLC6A4HTR1ASLC6A3HTR2C
SCHEMBL13726844 0.67 TDP1 (0.46) HTR6NR3C2
SCHEMBL330081 0.66 HTR2C (1.00) SLC6A2SLC6A4HTR1ASLC6A3HTR2C
SCHEMBL29891667 0.66 HTR2C (1.00) SLC6A2SLC6A4HTR1ASLC6A3HTR2C
SCHEMBL24716111 0.66 HTR2C (0.56) SLC6A2SLC6A4HTR1ASLC6A3HTR2C
SCHEMBL30626631 0.66 HTR2C (0.56) SLC6A2SLC6A4HTR1ASLC6A3HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598483-A1 AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME Rigel Pharmaceuticals, Inc. (US) 2013-06-05 — — EP disclosed
WO-2012016217-A1 AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME RIGEL PHARMACEUTICALS, INC. (US) 2012-02-02 — — WO disclosed
Send feedback